Israel - Englisch - Ministry of Health

cts ltd - asparaginase - powder for solution for injection - asparaginase 10000 iu/vial - asparaginase - asparaginase - acute lymphoblastic leukemia, acute myeloblastic leukemia.

Kanada - Englisch - Health Canada

jazz pharmaceuticals france sas - asparaginase - powder for solution - 10000unit - asparaginase 10000unit - antineoplastic agents

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

porton biopharma ltd - crisantaspase - powder for solution for injection - 10000unit

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

medac uk - asparaginase - powder for solution for infusion - 10000unit

Irland - Englisch - HPRA (Health Products Regulatory Authority)

porton biopharma limited - crisantaspase - powder for solution for injection/infusion - 10,000 unit(s) - asparaginase

Europäische Union - Englisch - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - crisantaspase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

jazz pharmaceuticals france sas - cristanspase - powder for solution for injection - 10000  international unit(s) - other antineoplastic agents; asparaginase

Singapur - Englisch - HSA (Health Sciences Authority)

kyowa kirin asia pacific pte. ltd. - l-asparaginase - injection, powder, for solution - 10000 iu/vial - l-asparaginase 10000 iu/vial

Malta - Englisch - Medicines Authority

medac gesellschaft fur klinische spezialpräparate mbh theaterstr. 6 22880 wedel, germany - l, asparaginase - powder for solution for injection - l-asparaginase 10000 iu - antineoplastic agents

Europäische Union - Englisch - EMA (European Medicines Agency)

medac gesellschaft fuer klinische spezialpraeparate mbh - asparaginase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents - spectrila is indicated as a component of antineoplastic combination therapy for the treatment of acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years and adults.